Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Ozempic, Wegovy Really Good Value: Novo Nordisk CEO
Posted
June 7, 2024
Views
1,209
Likes
16
Comments
3
Engagement
1.57%
June 7, 2024
1,209
16
3
1.57%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:28Now Playing#Ozempic #Wegovy #obesity #diabetes #weightloss #healthcare #pharmaceuticals #novonordisk #drugs #leadership #CEO
Novo Nordisk is Europe’s most valuable company with booming demand for its blockbuster diabetes and obesity drugs, Ozempic and Wegovy. They’re revolutionizing the weight loss drug industry, with some analysts predicting it could be worth up to $150 billion a year. But the company has faced criticism over its prices, with US Senator Bernie Sanders pressing the company to lower the cost of Wegovy. Speaking on Bloomberg’s Leaders With Lacqua, Novo Nordisk CEO Lars Fruergaard Jørgensen explains why he feels the Danish pharmaceutical giant’s drugs offer ‘really good’ value and how they can help to ease the strain on healthcare systems across the world.
Watch the full interview
#bloomberg #leaderswithlacqua #francinelacqua
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, uptotheminute market data, features, profiles and more.
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Bloomberg Radio
Bloomberg Surveillance
Bloomberg Politics
Bloomberg Originals
Watch more on YouTube:
Bloomberg Technology
Bloomberg Originals
Bloomberg Quicktake
Bloomberg Espanol
Bloomberg Podcasts
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
